Notably, the data suggest that MYC synthetic lethality is not necessarily contingent on simultaneous overexpression of both targets but rather, endogenous levels of molecular nodes such as BRD4 and CHK1 become critical to the survival of MYC‐addicted cancer cells. The gene discussed is BRD4; the disease is cancer.